Formulation and in vitro evaluation of ciprofloxacin containing niosomes for pulmonary delivery.
about
Niosomes of ascorbic acid and α-tocopherol in the cerebral ischemia-reperfusion model in male ratsIn-vitro and in-vivo evaluation of ciprofloxacin liposomes for pulmonary administration.Folated synperonic-cholesteryl hemisuccinate polymeric micelles for the targeted delivery of docetaxel in melanoma.Optimizing efficacy of mucosal vaccines.Recent advances in non-ionic surfactant vesicles (niosomes): self-assembly, fabrication, characterization, drug delivery applications and limitations.Epithelial profiling of antibiotic controlled release respiratory formulations.Effect of different types of surfactants on the physical properties and stability of carvedilol nano-niosomes.Fasudil and SOD packaged in peptide-studded-liposomes: Properties, pharmacokinetics and ex-vivo targeting to isolated perfused rat lungs.Pharmacokinetic study of niosome-loaded insulin in diabetic rats.Niosomes as a potential drug delivery system for increasing the efficacy and safety of nystatin.Optimization of niosomes for enhanced antibacterial activity and reduced bacterial resistance: in vitro and in vivo evaluation.Potentiating antimicrobial efficacy of propolis through niosomal-based system for administration.Development, physicochemical characterization, and antimicrobial evaluation of niosomal myrtle essential oil.
P2860
Q34177003-741CFC4A-0C26-4D84-8B02-20BF2C28F752Q35046837-F490EEC5-A62D-4DD9-8038-E472E44F6DD3Q35207269-E3CCD68D-EEDC-48CA-88C8-18CA99F1819DQ38059754-5AAE8D38-C08A-4504-A1EE-FCF439C66E02Q38155210-149C6879-62D8-4DC4-AB9E-89F48D4850FAQ39536127-D5474EDF-0A91-4297-AF4E-FD84D0F08230Q39776100-26D6F8AE-D403-442F-AC72-FF7388B76D21Q40854694-2FC82874-DC68-4C45-AFE6-2E5C8C061F7EQ42226107-0918B31D-3723-4A00-BCB4-928D0E72E251Q44837755-85A5B0CA-AEF3-4D01-A963-9831CB30CCC2Q46202238-D9A4B65B-35F0-4869-A1F2-D0B7ACCD9D3CQ53671461-29EE3795-C2A5-4E75-A421-E0325D7A4B24Q55003463-DB74BA42-7F37-4335-8009-CF5BE8DBCABB
P2860
Formulation and in vitro evaluation of ciprofloxacin containing niosomes for pulmonary delivery.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Formulation and in vitro evalu ...... osomes for pulmonary delivery.
@en
Formulation and in vitro evalu ...... osomes for pulmonary delivery.
@nl
type
label
Formulation and in vitro evalu ...... osomes for pulmonary delivery.
@en
Formulation and in vitro evalu ...... osomes for pulmonary delivery.
@nl
prefLabel
Formulation and in vitro evalu ...... osomes for pulmonary delivery.
@en
Formulation and in vitro evalu ...... osomes for pulmonary delivery.
@nl
P2093
P2860
P1476
Formulation and in vitro evalu ...... osomes for pulmonary delivery.
@en
P2093
Abbas Pardakhty
Abdolhossein Rouholamini Najafabadi
Esmaeil Moazeni
Farzaneh Sotoudegan
Hossein Jamalifar
Mohammad Reza Fazeli
Rouhollah Ghalandari
P2860
P304
P356
10.3109/02652048.2010.506579
P577
2010-01-01T00:00:00Z